These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8567331

  • 41. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 42. A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.
    Zhao H, Zhu W, Xie P, Li H, Zhang X, Sun X, Yu J, Xing L.
    Radiother Oncol; 2014 Jan; 110(1):132-6. PubMed ID: 24444526
    [Abstract] [Full Text] [Related]

  • 43. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer.
    Crinò L, Latini P, Meacci M, Corgna E, Maranzano E, Darwish S, Minotti V, Santucci A, Tonato M.
    Ann Oncol; 1993 Dec; 4(10):847-51. PubMed ID: 8117604
    [Abstract] [Full Text] [Related]

  • 44. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
    Byhardt RW, Scott C, Sause WT, Emami B, Komaki R, Fisher B, Lee JS, Lawton C.
    Int J Radiat Oncol Biol Phys; 1998 Oct 01; 42(3):469-78. PubMed ID: 9806503
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Therapeutic results of non-small cell lung cancer in stage III: combined synchronous irradiation with bronchial artery infusion of CDDP].
    Murakami M, Kuroda Y, Sano A, Noma S, Kanaoka N, Ishikura S, Yamada K, Takamori M, Mori T, Okada T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan 01; 55(1):44-9. PubMed ID: 7899064
    [Abstract] [Full Text] [Related]

  • 47. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.
    Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W.
    Int J Radiat Oncol Biol Phys; 2002 Jul 01; 53(3):548-57. PubMed ID: 12062596
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Neoadjuvant combined therapy in stage IIIA if non-small-cell bronchial cancer].
    Thomas M, Rübe C, Semik M, Junker K, von Eiff M.
    Dtsch Med Wochenschr; 1997 Aug 15; 122(33):993-8. PubMed ID: 9296933
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.
    Semin Oncol; 1996 Apr 15; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [Abstract] [Full Text] [Related]

  • 52. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M, Provencio M, Utracka-Hutka B, Villa E, Codes M, Kuten A, Henke M, Lopez M, Bell D, Biti G, Merimsky O, Beorchia A, Riggi M, Caux NR, Pouget JC, Dubray B, David P.
    J Thorac Oncol; 2008 Sep 15; 3(9):994-1002. PubMed ID: 18758302
    [Abstract] [Full Text] [Related]

  • 53. Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.
    Filipazzi V, Cattaneo MT, Rho B, Frontini L, D'Adda D, Isa L, Scapaticci R, Legnani W, Calzavara MP, Berni F.
    Oncology; 1993 Sep 15; 50(1):10-3. PubMed ID: 8380632
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M, Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
    Lung Cancer; 2005 Jul 15; 49(1):85-94. PubMed ID: 15949594
    [Abstract] [Full Text] [Related]

  • 56. [Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy].
    Kaneyasu Y, Okawa MK, Kokubo N, Karasawa K, Fukuhara N, Toda J, Okawa T.
    Gan To Kagaku Ryoho; 1997 Sep 15; 24(12):1813-6. PubMed ID: 9382539
    [Abstract] [Full Text] [Related]

  • 57. Bronchial artery infusion of mitomycin C in carcinoma of the lung.
    Ekholm S, Albrechtsson U, Tylén U.
    Cardiovasc Intervent Radiol; 1983 Sep 15; 6(2):86-96. PubMed ID: 6411341
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III nonsmall cell lung cancer.
    Jeremic B, Shibamoto Y.
    Int J Radiat Oncol Biol Phys; 1996 Jan 15; 34(2):303-8. PubMed ID: 8567330
    [Abstract] [Full Text] [Related]

  • 60. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
    Frasci G, Comella P, Scoppa G, Guida C, Gravina A, Fiore F, Casaretti R, Daponte A, Parziale A, Comella G.
    J Clin Oncol; 1997 Apr 15; 15(4):1409-17. PubMed ID: 9193333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.